Effect of a Probiotic Formula on Reducing SIBO in IBS Patients
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This randomized study evaluates the effectiveness of the a probiotic formula, compared with
the antibiotic rifaximin, in the treatment of Small Intestinal Bacterial Overgrowth (SIBO) in
Irritable Bowel Syndrome (IBS) patients.